Literature DB >> 10428432

Outcome of multiple subpial transections for autistic epileptiform regression.

R Nass1, A Gross, J Wisoff, O Devinsky.   

Abstract

Treatment options for atypical forms of Landau-Kleffner syndrome (LKS) are not well delineated. Many patients with typical LKS fail to respond to antiepileptic drug treatment, but some benefit from multiple subpial transections (MSTs). The authors report seven patients with autism or autistic epileptiform regression who responded in varying degrees to MSTs after failed medical management. These patients derived from an original cohort of 36 children (29 males, seven females, ranging from 2 years, 3 months to 11 years, 3 months, mean age = 5 years, 8 months) with a history of language delay or regression, as well as varying degrees of social and behavioral abnormalities, who were evaluated with video-electroencephalogram (EEG) monitoring over a 2-year period. Fifteen patients had clinical seizures (11 of the 19 children with autistic epileptiform regression and four of 12 autistic children). Epilepsy was refractory to medication in seven. Surgical treatment variously involved MSTs of the left neocortex in temporal, parietal, and frontal regions, often including regions within the classic perisylvian language areas. One patient also had a left temporal lobectomy. In all seven patients, seizure control or EEG improved after MSTs. Language, social, and overall behavior improved to a moderate degree, although improvements were temporary in most. Autistic epileptiform regression resembles LKS in that both may respond to MST. MST is used to treat epilepsy in eloquent regions. The responsiveness of autistic epileptiform regression to MST buttresses the argument that autistic epileptiform regression is a form of focal epilepsy.

Entities:  

Mesh:

Year:  1999        PMID: 10428432     DOI: 10.1016/s0887-8994(99)00029-6

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  11 in total

1.  Treatment of seizure disorders and EEG abnormalities in children with autism spectrum disorders.

Authors:  R Tuchman
Journal:  J Autism Dev Disord       Date:  2000-10

2.  Landau-Kleffner Syndrome.

Authors:  Andres M. Kanner
Journal:  Epilepsy Curr       Date:  2001-11       Impact factor: 7.500

Review 3.  Epilepsy in autism spectrum disorders.

Authors:  Roberto Canitano
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-08-24       Impact factor: 4.785

4.  Autistic spectrum disorder, epilepsy, and vagus nerve stimulation.

Authors:  Mariam Mettry Hull; Deepak Madhavan; Charles M Zaroff
Journal:  Childs Nerv Syst       Date:  2015-04-29       Impact factor: 1.475

Review 5.  Management of Landau-Kleffner syndrome.

Authors:  Mohamad A Mikati; Alhan N Shamseddine
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

6.  Risk factors of acute behavioral regression in psychiatrically hospitalized adolescents with autism.

Authors:  Didier Périsse; Claire Amiet; Angèle Consoli; Marie-Vincente Thorel; Isabelle Gourfinkel-An; Nicolas Bodeau; Vincent Guinchat; Catherine Barthélémy; David Cohen
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2010-05

Review 7.  Regression in autistic spectrum disorders.

Authors:  Gerry A Stefanatos
Journal:  Neuropsychol Rev       Date:  2008-10-28       Impact factor: 7.444

Review 8.  The role of epilepsy and epileptiform EEGs in autism spectrum disorders.

Authors:  Sarah J Spence; Mark T Schneider
Journal:  Pediatr Res       Date:  2009-06       Impact factor: 3.756

9.  The Landau-Kleffner Syndrome.

Authors:  Phillip L. Pearl; Enrique J. Carrazana; Gregory L. Holmes
Journal:  Epilepsy Curr       Date:  2001-11       Impact factor: 7.500

Review 10.  A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel.

Authors:  Richard E Frye; Daniel Rossignol; Manuel F Casanova; Gregory L Brown; Victoria Martin; Stephen Edelson; Robert Coben; Jeffrey Lewine; John C Slattery; Chrystal Lau; Paul Hardy; S Hossein Fatemi; Timothy D Folsom; Derrick Macfabe; James B Adams
Journal:  Front Public Health       Date:  2013-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.